Edition:
United Kingdom

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

25.50USD
18 Apr 2019
Change (% chg)

$0.11 (+0.43%)
Prev Close
$25.39
Open
$25.29
Day's High
$25.84
Day's Low
$24.67
Volume
14,169
Avg. Vol
24,574
52-wk High
$34.65
52-wk Low
$7.74

About

KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein... (more)

Overall

Beta: 2.44
Market Cap(Mil.): $439.81
Shares Outstanding(Mil.): 17.25
Dividend: --
Yield (%): --

Financials

  KALV.OQ Industry Sector
P/E (TTM): -- 57.23 57.80
EPS (TTM): -0.97 -- --
ROI: -17.23 12.21 11.82
ROE: -19.53 13.15 12.64

Earnings vs. Estimates